Hyperfine (HYPR) EBIT Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EBIT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 16.18% |
| 10 | Hyperfine | 88.36 Mn | 43.60 Mn | 1.98 Mn | 11.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.74% |
| Mar 31, 2026 | 21.50% |
| Dec 31, 2025 | 28.77% |
| Sep 30, 2025 | 18.64% |
| Jun 30, 2025 | 11.53% |
| Mar 31, 2025 | -2.37% |
| Dec 31, 2024 | 7.43% |
| Sep 30, 2024 | 6.77% |
| Jun 30, 2024 | 7.24% |
| Mar 31, 2024 | 18.30% |
| Dec 31, 2023 | 14.67% |
| Sep 30, 2023 | 11.47% |
| Jun 30, 2023 | 49.59% |
| Mar 31, 2023 | 45.16% |
| Dec 31, 2022 | 47.76% |
| Sep 30, 2022 | 18.96% |
| Jun 30, 2022 | -59.00% |
| Mar 31, 2022 | -204.56% |